跳至主要内容
临床试验/ACTRN12616000284460
ACTRN12616000284460尚未招募未知

Effects of a targeted exercise program on muscle function in men with non-metastatic prostate cancer receiving androgen deprivation therapy (ADT): a randomized, placebo-controlled trial

niversity of Melbourne0 个研究点目标入组 80 人开始时间: 2016年3月4日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
50 Years 至 80 Years(—)
性别
Male

入选标准

  • ADT naive men with localised non-metastatic prostate cancer (T1-3NxM0), age 50-80 years about to commence treatment with GnRH agonists to suppress androgen production, in whom treatment with ADT is intended for at least 12 months, who live independently in the community, and are ambulant, fully active, and unrestricted in their physical activities.

排除标准

  • 1) Impaired performance status (ECOG < 1), neuromuscular disease, or requiring a walking aid.
  • 2) Evidence of androgen deficiency or baseline serum total T <10nmol/L.
  • 3) Active cardiac, respiratory or joint disease affecting exercise tolerance or muscle function.
  • 4) Corticosteroid or recreational drug use, alcohol dependence or any disease likely to lead to serious illness or death within the study period.
  • 5) Participated in a regular strength training program (2 or more times per week for more than 6 weeks) in the last 12 months.

研究者

发起方
niversity of Melbourne

相似试验